Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications-Reference-Cited by-同舟云学术

Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications

Published:2020-12-29 Issue:1 Volume:14 Page:95-103
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Charan Jaykaran¹^ORCID,Kaur Rimple Jeet²,Bhardwaj Pankaj³,Haque Mainul⁴^ORCID,Sharma Praveen⁵^ORCID,Misra Sanjeev⁶,Godman Brian⁷⁸⁹¹⁰^ORCID

Affiliation:

1. Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India

2. Department of Pharmacology, S.N. Medical College, Jodhpur, India

3. Department of Community and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India

4. Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia

5. Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

6. Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India

7. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

8. School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

9. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

10. Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1856655

Reference65 articles.

1. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus

2. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

3. Treatment of COVID-19: old tricks for new challenges

4. Current pharmacological treatments for COVID‐19: What's next?

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological Changes;Cureus;2024-09-01

2. Effects of Remdesivir on liver enzymes, oxidative stress and Liver histopathology in rats;2024-06-13

3. Assessing the effect of remdesivir alone and in combination with corticosteroids on time to death in COVID-19: A propensity score-matched analysis;Journal of Clinical Virology Plus;2024-06

4. ACE2 Receptor‐Targeted Inhaled Nanoemulsions Inhibit SARS‐CoV‐2 and Attenuate Inflammatory Responses;Advanced Materials;2024-01-04

5. A Sensitive and Validated Extractive-Spectrophotometric Determination of Remdesivir;Jordan Journal of Chemistry;2023-12-30